Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study.

Ying T, Gill J, Webster A, Kim SJ, Morton R, Klarenbach SW, Kelly P, Ramsay T, Knoll GA, Pilmore H, Hughes G, Herzog CA, Chadban S, Gill JS.

Am Heart J. 2019 May 22;214:175-183. doi: 10.1016/j.ahj.2019.05.008. [Epub ahead of print]

PMID:
31228771
2.

Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Tonelli M, Wiebe N, Kovesdy CP, James MT, Klarenbach SW, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9.

3.

The Cost of Care for People With Chronic Kidney Disease.

Manns B, Hemmelgarn B, Tonelli M, Au F, So H, Weaver R, Quinn AE, Klarenbach S; for Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease.

Can J Kidney Health Dis. 2019 Apr 4;6:2054358119835521. doi: 10.1177/2054358119835521. eCollection 2019.

4.

Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.

James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.

JAMA Netw Open. 2019 Apr 5;2(4):e191795. doi: 10.1001/jamanetworkopen.2019.1795.

5.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

6.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

7.

Non-reimbursed costs incurred by living kidney donors: A case study from Ontario, Canada.

Barnieh L, Klarenbach S, Arnold J, Cuerden M, Knoll G, Lok C, Sontrop JM, Miller M, Prasad GVR, Przech S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002685. [Epub ahead of print]

PMID:
30830039
8.

A cardiac magnetic resonance imaging study of long-term and incident hemodialysis patients.

Thompson RB, Raggi P, Wiebe N, Ugander M, Nickander J, Klarenbach SW, Thompson S, Tonelli M; Alberta Kidney Disease Network.

J Nephrol. 2019 Aug;32(4):615-626. doi: 10.1007/s40620-019-00593-3. Epub 2019 Feb 18.

PMID:
30778918
9.

Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system.

Osman MA, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B, Courtney M, Feehally J, Harris DC, Jha V, Jindal K, Johnson DW, Kalantar-Zadeh K, Kazancioglu R, Klarenbach S, Levin A, Lunney M, Okpechi IG, Olanrewaju TO, Perl J, Rashid HU, Rondeau E, Salako BL, Samimi A, Sola L, Tchokhonelidze I, Wiebe N, Yang CW, Ye F, Zemchenkov A, Zhao MH, Bello AK.

Kidney Int Suppl (2011). 2018 Feb;8(2):52-63. doi: 10.1016/j.kisu.2017.10.009. Epub 2018 Jan 19. Review.

10.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e190147.

11.

Developing key performance indicators for prescription medication systems.

Spackman E, Clement F, Allan GM, Bell CM, Bjerre LM, Blackburn DF, Blais R, Hazlewood G, Klarenbach S, Nicolle LE, Persaud N, Alessi-Severini S, Tierney M, Wijeysundera HC, Manns B.

PLoS One. 2019 Jan 15;14(1):e0210794. doi: 10.1371/journal.pone.0210794. eCollection 2019.

12.

Strategies for incorporating patient-reported outcomes in the care of people with chronic kidney disease (PRO kidney): a protocol for a realist synthesis.

Schick-Makaroff K, Thummapol O, Thompson S, Flynn R, Karimi-Dehkordi M, Klarenbach S, Sawatzky R, Greenhalgh J.

Syst Rev. 2019 Jan 12;8(1):20. doi: 10.1186/s13643-018-0911-6.

13.

Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.

Padwal RS, So H, Wood PW, Mcalister FA, Siddiqui M, Norris CM, Jeerakathil T, Stone J, Valaire S, Mann B, Boulanger P, Klarenbach SW.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):159-168. doi: 10.1111/jch.13459. Epub 2018 Dec 20.

14.

Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.

Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, Doull M, Courage S, Garcia AJ, Thombs BD; Canadian Task Force on Preventive Health Care.

CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463. No abstract available.

15.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

16.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.

Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N; Interdisciplinary Chronic Disease Collaboration .

JAMA Intern Med. 2018 Dec 1;178(12):1681-1690. doi: 10.1001/jamainternmed.2018.4749.

PMID:
30422153
17.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, Gill JS, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Dec;29(12):2847-2857. doi: 10.1681/ASN.2018040398. Epub 2018 Nov 7.

PMID:
30404908
18.

Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet].

Sinclair A, Cimon K, Loncar M, Sood M, Komenda P, Severn M, Klarenbach S, So H, Tsoi B, Quinn R, Pauly R, Tonelli M, Manns B, Rader T, Moulton K, Moulton K, Helis E, Crain J, Pullman D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar.

19.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance specialist access to care: a scoping review protocol.

Osman MA, Schick-Makaroff K, Thompson S, Featherstone R, Bialy L, Kurzawa J, Okpechi IG, Habib S, Shojai S, Jindal K, Klarenbach S, Bello AK.

BMJ Open. 2018 Sep 28;8(9):e022733. doi: 10.1136/bmjopen-2018-022733.

20.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

21.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
22.

Hospitalizations in Dialysis Patients in Canada: A National Cohort Study.

Molnar AO, Moist L, Klarenbach S, Lafrance JP, Kim SJ, Tennankore K, Perl J, Kappel J, Terner M, Gill J, Sood MM.

Can J Kidney Health Dis. 2018 Jun 1;5:2054358118780372. doi: 10.1177/2054358118780372. eCollection 2018.

23.

Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.

Kadatz M, Klarenbach S, Gill J, Gill JS.

Am J Transplant. 2018 Oct;18(10):2457-2464. doi: 10.1111/ajt.14929. Epub 2018 Jun 14.

PMID:
29797402
24.

Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings.

Wilson BJ, Courage S, Bacchus M, Dickinson JA, Klarenbach S, Jaramillo Garcia A, Sims-Jones N, Thombs BD; Canadian Task Force on Preventive Health Care.

CMAJ. 2018 May 14;190(19):E588-E594. doi: 10.1503/cmaj.171430. No abstract available.

25.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
26.

Validation of Living Donor Nephrectomy Codes.

Lam NN, Lentine KL, Klarenbach S, Sood MM, Kuwornu PJ, Naylor KL, Knoll GA, Kim SJ, Young A, Garg AX.

Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018.

27.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

28.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

29.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
30.
31.

Health care costs associated with hospital acquired complications in patients with chronic kidney disease.

Bohlouli B, Jackson T, Tonelli M, Hemmelgarn B, Klarenbach S.

BMC Nephrol. 2017 Dec 28;18(1):375. doi: 10.1186/s12882-017-0784-2.

32.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

33.

Direct and indirect costs incurred by Australian living kidney donors.

Barnieh L, Kanellis J, McDonald S, Arnold J, Sontrop JM, Cuerden M, Klarenbach S, Garg AX, Boudville N; Donor Nephrectomy Outcomes Research (DONOR) Network.

Nephrology (Carlton). 2018 Dec;23(12):1145-1151. doi: 10.1111/nep.13205.

PMID:
29215180
34.

The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice.

Barbour S, Lo C, Espino-Hernandez G, Sajjadi S, Feehally J, Klarenbach S, Gill J.

Nephrol Dial Transplant. 2018 Apr 1;33(4):626-634. doi: 10.1093/ndt/gfx185.

PMID:
29106654
35.

Health Care Costs Associated with AKI.

Collister D, Pannu N, Ye F, James M, Hemmelgarn B, Chui B, Manns B, Klarenbach S; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1733-1743. doi: 10.2215/CJN.00950117. Epub 2017 Oct 19.

36.

Serum 25-Hydroxyvitamin D Concentrations and Indicators of Mental Health: An Analysis of the Canadian Health Measures Survey.

Chu F, Ohinmaa A, Klarenbach S, Wong ZW, Veugelers P.

Nutrients. 2017 Oct 13;9(10). pii: E1116. doi: 10.3390/nu9101116.

37.

Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.

PMID:
28838766
38.

A Scoping Review for Strategies to Increase Living Kidney Donation.

Barnieh L, Collister D, Manns B, Lam NN, Shojai S, Lorenzetti D, Gill JS, Klarenbach S.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1518-1527. doi: 10.2215/CJN.01470217. Epub 2017 Aug 17. Review.

39.

Multimorbidity, dementia and health care in older people:a population-based cohort study.

Tonelli M, Wiebe N, Straus S, Fortin M, Guthrie B, James MT, Klarenbach SW, Tam-Tham H, Lewanczuk R, Manns BJ, Quan H, Ronksley PE, Sargious P, Hemmelgarn B; Alberta Kidney Disease Network.

CMAJ Open. 2017 Aug 14;5(3):E623-E631. doi: 10.9778/cmajo.20170052.

40.

Quality Assurance Audit of Technique Failure and 90-Day Mortality after Program Discharge in a Canadian Home Hemodialysis Program.

Shah N, Reintjes F, Courtney M, Klarenbach SW, Ye F, Schick-Makaroff K, Jindal K, Pauly RP.

Clin J Am Soc Nephrol. 2017 Jul 24. pii: CJN.00140117. doi: 10.2215/CJN.00140117. [Epub ahead of print]

41.

Adverse Outcomes Associated with Preventable Complications in Hospitalized Patients with CKD.

Bohlouli B, Jackson TJ, Tonelli M, Hemmelgarn B, Klarenbach S.

Clin J Am Soc Nephrol. 2017 May 8;12(5):799-806. doi: 10.2215/CJN.09410916. Epub 2017 Apr 27.

42.

Recommendations on hepatitis C screening for adults.

Grad R, Thombs BD, Tonelli M, Bacchus M, Birtwhistle R, Klarenbach S, Singh H, Dorais V, Holmes NM, Martin WK, Rodin R, Jaramillo Garcia A; Canadian Task Force on Preventive Health Care.

CMAJ. 2017 Apr 24;189(16):E594-E604. doi: 10.1503/cmaj.161521. No abstract available.

43.

Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults.

Lester EL, Padwal R, Majumdar SR, Ye F, Birch DW, Klarenbach SW.

Value Health. 2017 Apr;20(4):694-698. doi: 10.1016/j.jval.2016.04.016. Epub 2016 Jun 28.

44.

Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.

Lam NN, Tonelli M, Lentine KL, Hemmelgarn B, Ye F, Wen K, Klarenbach S.

Kidney Int. 2017 Aug;92(2):470-478. doi: 10.1016/j.kint.2017.01.028. Epub 2017 Mar 31.

PMID:
28366228
45.

Choosing Wisely: The Canadian Society of Nephrology's List of 5 Items Physicians and Patients Should Question.

Chan E, Hemmelgarn B, Klarenbach S, Manns B, Mustafa R, Nesrallah G, McQuillan R.

Can J Kidney Health Dis. 2017 Feb 28;4:2054358117695570. doi: 10.1177/2054358117695570. eCollection 2017.

46.

Patient and provider perspectives on the design and implementation of an electronic consultation system for kidney care delivery in Canada: a focus group study.

Bello AK, Molzahn AE, Girard LP, Osman MA, Okpechi IG, Glassford J, Thompson S, Keely E, Liddy C, Manns B, Jinda K, Klarenbach S, Hemmelgarn B, Tonelli M.

BMJ Open. 2017 Mar 2;7(3):e014784. doi: 10.1136/bmjopen-2016-014784.

47.

The evaluating self-management and educational support in severely obese patients awaiting multidisciplinary bariatric care (EVOLUTION) trial: principal results.

Padwal RS, Klarenbach S, Sharma AM, Fradette M, Jelinski SE, Edwards A, Majumdar SR.

BMC Med. 2017 Mar 2;15(1):46. doi: 10.1186/s12916-017-0808-6.

48.

Providing Coverage for the Unique Lifelong Health Care Needs of Living Kidney Donors Within the Framework of Financial Neutrality.

Gill JS, Delmonico F, Klarenbach S, Capron AM.

Am J Transplant. 2017 May;17(5):1176-1181. doi: 10.1111/ajt.14147. Epub 2017 Jan 9.

49.

A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery.

Pannu N, Graham M, Klarenbach S, Meyer S, Kieser T, Hemmelgarn B, Ye F, James M; APPROACH Investigators and the Alberta Kidney Disease Network.

CMAJ. 2016 Oct 18;188(15):1076-1083. doi: 10.1503/cmaj.151447. Epub 2016 Jun 13.

50.

Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2×2 factorial randomized trial.

Campbell DJ, Tonelli M, Hemmelgarn B, Mitchell C, Tsuyuki R, Ivers N, Campbell T, Pannu R, Verkerke E, Klarenbach S, King-Shier K, Faris P, Exner D, Chaubey V, Manns B; Interdisciplinary Chronic Disease Collaboration.

Implement Sci. 2016 Sep 26;11(1):131.

Supplemental Content

Loading ...
Support Center